We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+8.08%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$408B
AUM Growth
+$23B
Cap. Flow
+$1.72B
Cap. Flow %
0.42%
Top 10 Hldgs %
28.09%
Holding
14,143
New
3,275
Increased
5,446
Reduced
4,187
Closed
1,034

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$627M
2
BIDU icon
Baidu
BIDU
+$542M
3
MBB icon
iShares MBS ETF
MBB
+$492M
4
NVDA icon
NVIDIA
NVDA
+$429M
5
CMCSA icon
Comcast
CMCSA
+$421M

Sector Composition

Rank Sector Weight
1 Technology 3.86%
2 Healthcare 3.34%
3 Consumer Discretionary 2.41%
4 Financials 2.35%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TV icon
12376
CALL
Televisa
TV
$1.52B
$94K ﹤0.01%
10,600
-10,000
-49% -$85K
VHAQ.RT
12377
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$94K ﹤0.01%
+520,832
New +$122K
ITCL
12378
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
$94K ﹤0.01%
+15,973
New +$87.4K
SPPI
12379
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$94K ﹤0.01%
28,700
+8,200
+40% +$29.4K
MIT.WS
12380
DELISTED
Mason Industrial Technology, Inc. Redeemable warrants, exercisable for one share of Class A common stock for $11.50 per share
MIT.WS
$94K ﹤0.01%
+149,119
New +$97.3K
AMRX icon
12381
PUT
Amneal Pharmaceuticals
AMRX
$6.17B
$93K ﹤0.01%
13,800
-8,100
-37% -$44.9K
ASMB icon
12382
CALL
Assembly Biosciences
ASMB
$642M
$93K ﹤0.01%
1,692
-175
-9% -$11.6K
LCTX icon
12383
PUT
Lineage Cell Therapeutics
LCTX
$271M
$93K ﹤0.01%
+39,500
New +$94.9K
SGMA
12384
DELISTED
Sigmatron International
SGMA
$93K ﹤0.01%
+17,324
New +$94.5K
TGS icon
12385
CALL
Transportadora de Gas del Sur
TGS
$4.24B
$93K ﹤0.01%
+19,200
New +$95.2K
BXRX
12386
CALL
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$93K ﹤0.01%
52
+37
+247% +$74K
AXAS
12387
CALL
DELISTED
Abraxas Petroleum Corp
AXAS
$93K ﹤0.01%
+29,700
New +$102K
FWP
12388
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$93K ﹤0.01%
+13,514
New +$98.2K
ADAP
12389
PUT
DELISTED
Adaptimmune Therapeutics
ADAP
$92K ﹤0.01%
+17,400
New +$99.6K
ANIX icon
12390
Anixa Biosciences
ANIX
$109M
$92K ﹤0.01%
19,682
+5,184
+36% +$24.8K
AWRE icon
12391
Aware
AWRE
$26.6M
$92K ﹤0.01%
+25,106
New +$107K
CARV
12392
DELISTED
Carver Bancorp
CARV
$92K ﹤0.01%
+10,182
New +$92K
ELTK icon
12393
Eltek
ELTK
$57.9M
$92K ﹤0.01%
+14,901
New +$85.1K
GURE
12394
Gulf Resources
GURE
$4.85M
$92K ﹤0.01%
+2,146
New +$94.7K
UONEK icon
12395
Urban One Class D
UONEK
$23.2M
$92K ﹤0.01%
+5,235
New +$88.2K
WVVI icon
12396
Willamette Valley Vineyards
WVVI
$11.5M
$92K ﹤0.01%
+10,191
New +$78.1K
UOKA
12397
DELISTED
MDJM Ltd
UOKA
$92K ﹤0.01%
+25
New +$97.4K
FGH
12398
CALL
DELISTED
FG Group Holdings Inc.
FGH
$92K ﹤0.01%
+35,100
New +$86.9K
INFI
12399
PUT
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$92K ﹤0.01%
28,400
+16,200
+133% +$54K
CNCE
12400
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$92K ﹤0.01%
+18,390
New +$149K

Similar funds

Ken Griffin's Q1 2021 Portfolio in Review

As of Q1 2021, Ken Griffin held 14,143 positions worth $408B, up 6% from $385B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q1 2021 filing shows 3,275 new, 5,446 increased, 4,187 reduced and 1,034 closed positions. Its largest new stake was SVB Financial Group: 445,853 shares worth $220M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.29B.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q1 2021 buy was SVB Financial Group: 445,853 shares worth $220M.
  • Ken Griffin added most to Amazon in Q1 2021, an estimated $627M increase.
  • Ken Griffin's biggest Q1 2021 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.29B.
  • Ken Griffin fully exited iShares MSCI Emerging Markets ETF in Q1 2021, selling an estimated $321M.
  • Ken Griffin's ten largest holdings make up 28% of its $408B portfolio in Q1 2021.
  • Ken Griffin opened 3,275 new positions and closed 1,034 in Q1 2021.
  • Ken Griffin's portfolio value rose 6% quarter-over-quarter to $408B.

Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.